Aigen Investment Management, LP Biomarin Pharmaceutical Inc Transaction History

Aigen Investment Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $129,391 - $143,704	1,521 Added 21.21%	8,691 $768,000
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $621,495 - $719,151	7,170 New	7,170 $621,000
Q2 2022 Aug 02, 2022	SELL	$71.48 - $86.85 $340,459 - $413,666	-4,763 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$74.28 - $92.69 $36,917 - $46,066	-497 Reduced 9.45%	4,763 $367,000
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $377,247 - $481,132	5,260 New	5,260 $446,000
Q2 2021 Aug 10, 2021	SELL	$75.51 - $84.79 $552,506 - $620,408	-7,317 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$74.73 - $90.69 $546,799 - $663,578	7,317 New	7,317 $553,000
Q2 2020 Aug 10, 2020	SELL	$79.55 - $124.22 $85,198 - $133,039	-1,071 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$71.37 - $96.85 $76,437 - $103,726	1,071 New	1,071 $91,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.